Variant report
Variant | nsv613688 |
---|---|
Chromosome Location | chr9:16941006-16955901 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs548493102 | chr9:16943028-16943029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs1538590 | chr9:16943046-16943047 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs114750977 | chr9:16943047-16943048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73646737 | chr9:16943104-16943105 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs570167822 | chr9:16943138-16943139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570016075 | chr9:16943178-16943179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs534424645 | chr9:16943183-16943184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184951090 | chr9:16943197-16943198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs141631741 | chr9:16943207-16943208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535755966 | chr9:16943238-16943239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10962748 | chr9:16943243-16943244 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs576025900 | chr9:16943270-16943271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs546370267 | chr9:16943282-16943283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188216751 | chr9:16943288-16943289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs573364158 | chr9:16943330-16943331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs193157965 | chr9:16943357-16943358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs184691182 | chr9:16943369-16943370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561911564 | chr9:16943384-16943385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs1890641 | chr9:16943412-16943413 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs10962749 | chr9:16943452-16943453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563571447 | chr9:16943454-16943455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1890642 | chr9:16943455-16943456 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs375637561 | chr9:16943482-16943483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551914814 | chr9:16943491-16943492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs368540237 | chr9:16943503-16943504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs553377733 | chr9:16943504-16943505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1538591 | chr9:16943514-16943515 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs546706338 | chr9:16943515-16943516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568076940 | chr9:16943528-16943529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535399777 | chr9:16943532-16943533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550306193 | chr9:16943539-16943540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7855568 | chr9:16943605-16943606 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs367608376 | chr9:16943606-16943607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558378589 | chr9:16943636-16943637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573504824 | chr9:16943643-16943644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs189402446 | chr9:16943695-16943696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs371340593 | chr9:16943726-16943727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs555798198 | chr9:16943735-16943736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560955418 | chr9:16943743-16943744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574072291 | chr9:16943767-16943768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577525908 | chr9:16949805-16949806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112161741 | chr9:16949819-16949820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs12349681 | chr9:16949833-16949834 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs148721363 | chr9:16949839-16949840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs142205249 | chr9:16949847-16949848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs114184515 | chr9:16949873-16949874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182725662 | chr9:16949881-16949882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs531686702 | chr9:16949900-16949901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs75383077 | chr9:16949921-16949922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs10962762 | chr9:16949930-16949931 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:16943000-16943800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr9:16949800-16950400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr9:16949800-16950600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr9:16950200-16950600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr9:16950200-16950600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr9:16950200-16950600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr9:16954400-16954600 | Enhancers | Fetal Kidney | kidney |